STOCK TITAN

Vision Sensing Acquisition Corp. Warrants - VSACW STOCK NEWS

Welcome to our dedicated page for Vision Sensing Acquisition Warrants news (Ticker: vsacw), a resource for investors and traders seeking the latest updates and insights on Vision Sensing Acquisition Warrants stock.

Vision Sensing Acquisition Corp (symbol: VSACW) is a blank check company formed to facilitate business combinations. The company aims to merge, acquire assets, or reorganize with potential businesses. Recently, VSAC announced a merger agreement with Mediforum Co., Ltd, a biotechnology company based in Korea. If the proposed business combination is completed, Mediforum will become a publicly listed company, expected to trade on NASDAQ under a new ticker symbol. Mediforum specializes in ethical drugs, diagnostic reagents, and strategic application products.

The merger agreement with Mediforum signifies a strategic move by Vision Sensing Acquisition Corp to expand its portfolio and enter the biotechnology sector. The combined company's listing on NASDAQ will provide visibility and access to capital markets, potentially driving growth and development opportunities for both entities.

Rhea-AI Summary

Vision Sensing Acquisition Corp (NASDAQ: VSAC) has announced the suspension of its securities from trading after October 25, 2024. The company will pay a per-share redemption price of $11.84 to holders of public shares on October 30, 2024. Following notification to Nasdaq on October 8 about failure to deposit required extension fees, VSAC is seeking voluntary delisting.

The company's trust account balance stands at approximately $13,427,746.07 as of October 18, with 1,133,691 remaining public shares. $100,000 will be retained for dissolution expenses, and $88,102 will be used for tax payments. Beneficial owners holding shares in 'street name' need not take action to receive redemption amounts. Company warrants will expire worthless.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
-
Rhea-AI Summary

Vision Sensing Acquisition Corp (NASDAQ: VSACU, VSAC, VSACW) announced its delisting and liquidation due to failure to complete a business combination by the required deadline. Key points:

1. The Sponsor did not deposit the extension fee by October 3, 2024.
2. VSAC will voluntarily delist from Nasdaq.
3. The company will dissolve and liquidate as per its charter.
4. Public shareholders will receive approximately $11.92 per share in redemption.
5. The trust account balance as of October 18, 2024, was about $13,515,848.07.
6. There were 1,133,691 public shares outstanding as of October 18, 2024.
7. Warrants will expire worthless.
8. The company will cease all operations except for winding up after October 21, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
-
Rhea-AI Summary

Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW), a special purpose acquisition company, has announced its intention to extend the deadline for completing its initial business combination from October 3, 2024, to November 3, 2024. This marks the sixth and final one-month extension authorized under the company's amended certificate of incorporation.

To facilitate this extension, the company's sponsor, Vision Sensing, , plans to deposit $51,016.10 into the company's trust account by July 3, 2024. In exchange, the company will issue a non-interest bearing, unsecured promissory note to the sponsor for the same amount. This extension aims to provide Vision Sensing Acquisition Corp. with additional time to finalize an initial business combination.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
Rhea-AI Summary

Vision Sensing Acquisition Corp. (NASDAQ: VSAC) has announced a payment to extend its deadline for completing an initial business combination. The company's sponsor, Vision Sensing, , deposited $51,016.10 into the trust account on August 2, 2024. This extension moves the deadline from September 3, 2024, to October 3, 2024.

This marks the fifth of six possible one-month extensions allowed under the company's recently amended certificate of incorporation. The extension provides Vision Sensing Acquisition Corp. with additional time to finalize a business combination. The amendment allowing these extensions was made on April 30, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Vision Sensing Acquisition Corp. (NASDAQ: VSAC) has announced its intention to extend the deadline for completing its initial business combination from September 3, 2024, to October 3, 2024. This marks the fifth of six possible one-month extensions authorized under the company's amended certificate of incorporation. To facilitate this extension, Vision Sensing, , the company's sponsor, plans to deposit $51,016.10 into the trust account by July 3, 2024. In exchange, the company will issue a non-interest bearing, unsecured promissory note to the sponsor for the same amount. This extension aims to provide Vision Sensing Acquisition Corp. with additional time to finalize an initial business combination.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Vision Sensing Acquisition Corp. (VSAC) has terminated its agreement with Mediforum Co., and entered into a non-binding letter of intent with Convergence CT, Inc. (CCT) for a business combination. The deal values CCT at $135 million, with $110 million paid upfront and the remainder subject to an earn-out. CCT specializes in smart hospital information systems and optimizing hospital workflows using IoT and AI. The combined company is expected to trade on NASDAQ post-closing. The transaction includes a 6-month lock-up period for issued shares and the formation of a 5-member board of directors. The parties aim to sign a binding agreement by August 31, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

Vision Sensing Acquisition Corp. (NASDAQ: VSAC) has announced a significant development in its pursuit of an initial business combination. The company's sponsor, Vision Sensing, , has deposited $51,016.10 into the trust account to extend the deadline for completing the combination from August 3, 2024, to September 3, 2024. This marks the fourth of six possible one-month extensions allowed under the company's recently amended certificate of incorporation.

The extension is important for Vision Sensing Acquisition Corp. as it provides additional time to finalize its Business Combination with Mediforum Co. , a Korean company. This merger agreement, initially dated January 12, 2024, is now given more time for completion. The move demonstrates the company's commitment to ensuring a successful merger and highlights the complex nature of international business combinations in the SPAC sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
-
Rhea-AI Summary

Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW), a special purpose acquisition company, has announced its intention to extend the deadline for completing its initial business combination from August 3, 2024, to September 3, 2024. This marks the fourth of up to six one-month extensions authorized under the company's amended certificate of incorporation. To facilitate this extension, the company's sponsor, Vision Sensing, , plans to deposit $51,016.10 into the trust account by July 3, 2024. In return, the company will issue a non-interest bearing, unsecured promissory note to the sponsor. This extension is aimed at providing additional time for Vision Sensing to complete its initial business combination, which is currently planned with Mediforum Co. , a Korean company, under an Agreement and Plan of Merger dated January 12, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) has successfully applied to migrate from the Nasdaq Global Market to the Nasdaq Capital Market, effective July 19, 2024. This move comes after a series of events, including a delisting notice in January 2024, regaining compliance with Listing Rule 5250(c)(1) in February, and a Nasdaq Hearings Panel granting an extension to transfer listings by July 15, 2024. The company has taken steps to meet Nasdaq Capital Market requirements, including converting 2,530,000 Series B shares into Series A shares to comply with the Market Value of Listed Securities Requirement. VSAC's management presented a viable plan to regain compliance while pursuing a business combination, demonstrating their commitment to maintaining their Nasdaq listing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

Vision Sensing Acquisition Corp. (NASDAQ: VSAC) has announced it has extended the deadline to complete its initial business combination to August 3, 2024. The extension was made possible by a $51,016.10 deposit made by its sponsor into the company’s trust account on July 2, 2024. This marks the third out of six possible one-month extensions permissible under the company's amended certificate of incorporation as of April 30, 2024.

The purpose of the extension is to provide the company additional time to finalize its merger with Mediforum Co. , a Korean company, as per the merger agreement signed on January 12, 2024. The company aims to use this extra time to ensure a smooth and successful completion of the business combination.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.39%
Tags

FAQ

What is the current stock price of Vision Sensing Acquisition Warrants (vsacw)?

The current stock price of Vision Sensing Acquisition Warrants (vsacw) is $0.0002 as of October 25, 2024.

What is Vision Sensing Acquisition Corp's core business?

Vision Sensing Acquisition Corp is a blank check company formed for facilitating business combinations.

What recent announcement did VSAC make?

VSAC announced a definitive Agreement and Plan of Merger with Mediforum Co., Ltd.

Who is Mediforum Co., Ltd, and what is their specialization?

Mediforum Co., Ltd is a biotechnology company based in Korea that specializes in ethical drugs, diagnostic reagents, and strategic application products.

Where is the combined company expected to be listed post-closing of the merger?

The combined company is expected to trade on NASDAQ under a new ticker symbol.

What are the contact details for individuals at Mediforum Co., Ltd and Norwich Capital Limited?

For Mediforum: Chankyu Kim (kimchankyu@gmediforum.com) and Jae Eon Jung (jejung@gmediforum.com). For Norwich Capital Limited: Jason Wong (enquiry@norwichhk.com).

Vision Sensing Acquisition Corp. Warrants

Nasdaq:VSACW

VSACW Rankings

VSACW Stock Data

1.61M
Shell Companies
Blank Checks
United States of America
MIAMI